Barclays analyst J. David Anderson lowered the firm’s price target on Aspen Aerogels (ASPN) to $13 from $25 and keeps an Overweight rating on the shares. The firm says that as a supplier of thermal barrier protection for electric vehicle batteries, the EV demand outlook has “meaningfully shifted” under President Trump, forcing Aspen to shift its expansion plans to a piecemeal approach relying on external manufacturing.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ASPN:
- Aspen Aerogels’ Strong 2024 Growth Amid Cautious 2025 Outlook
- Aspen Aerogels price target lowered to $16 from $22 at Roth MKM
- Aspen Aerogels price target lowered to $13 from $32 at Oppenheimer
- Aspen Aerogels price target lowered to $15 from $20 at Canaccord
- Aspen Aerogels Reports Strong FY 2024 Earnings Growth